MovDisordV3, PascalFrancis, Corpus, bibRecord, 000F25

Dysautonomia Rating Scales in Parkinson's Disease : Sialorrhea, Dysphagia, and Constipation-Critique and Recommendations by Movement Disorders Task Force on Rating Scales for Parkinson's Disease

Identifieur interne : 000F25 ( PascalFrancis/Corpus ); précédent : 000F24; suivant : 000F26

Dysautonomia Rating Scales in Parkinson's Disease : Sialorrhea, Dysphagia, and Constipation-Critique and Recommendations by Movement Disorders Task Force on Rating Scales for Parkinson's Disease

Auteurs : Marian L. Evatt ; K. Ray Chaudhuri ; Kelvin L. Chou ; Ester Cubo ; Vanessa Hinson ; Katie Kompoliti ; CHENGWU YANG ; Werner Poewe ; Olivier Rascol ; Cristina Sampaio ; Glenn T. Stebbins ; Christopher G. Goetz

Source :

Movement disorders [ 0885-3185 ] ; 2009.

RBID : Pascal:09-0218136

Descripteurs français

Pascal (Inist)
- Maladie de Parkinson, Dysphagie, Constipation, Pathologie du système nerveux, Sialorrhée, Recommandation, Force, Gastrointestinal.

English descriptors

KwdEn :
- Constipation, Dysphagia, Force, Gastrointestinal, Nervous system diseases, Parkinson disease, Recommendation, Sialorrhea.

Abstract

Upper and lower gastrointestinal dysautonomia symptoms (GIDS)-sialorrhea, dysphagia, and constipation are common in Parkinson's disease (PD) and often socially as well as physically disabling for patients. Available invasive quantitative measures for assessing these symptoms and their response to therapy are time-consuming, require specialized equipment, can cause patient discomfort and present patients with risk. The Movement Disorders Society commissioned a task force to assess available clinical rating scales, critique their clinimetric properties, and make recommendations regarding their clinical utility. Six clinical researchers and a biostatistician systematically searched the literature for scales of sialorrhea, dysphagia, and constipation, evaluated the scales' previous use, performance parameters, and quality of validation data (if available). A scale was designated "Recommended" if the scale was used in clinical studies beyond the group that developed it, has been specifically used in PD reports, and clinimetric studies have established that it is a valid, reliable, and sensitive. "Suggested" scales met at least part of the above criteria, but fell short of meeting all. Based on the systematic review, scales for individual symptoms of sialorrhea, dysphagia, and constipation were identified along with three global scales that include these symptoms in the context of assessing dysautonomia or nonmotor symptoms. Three sialorrhea scales met criteria for Suggested: Drooling Severity and Frequency Scale (DSFS), Drooling Rating Scale, and Sialorrhea Clinical Scale for PD (SCS-PD). Two dysphagia scales, the Swallowing Disturbance Questionnaire (SDQ) and Dysphagia-Specific Quality of Life (SWAL-QOL), met criteria for Suggested. Although Rome III constipation module is widely accepted in the gastroenterology community, and the earlier version from the Rome II criteria has been used in a single study of PD patients, neither met criteria for Suggested or Recommended. Among the global scales, the Scales for Outcomes in PD-Autonomic (SCOPA-AUT) and Nonmotor Symptoms Questionnaire for PD (NMSQuest) both met criteria for Recommended, and the Nonmotor Symptoms Scale (NMSS) met criteria for Suggested; however, none specifically focuses on the target gastrointestinal symptoms (sialorrhea, dysphagia, and constipation) of this report. A very small number of rating scales have been applied to studies of gastrointestinal-related dysautonomia in PD. Only two scales met "Recommended" criteria and neither focuses specifically on the symptoms of sialorrhea, dysphagia, and constipation. Further scale testing in PD among the scales that focus on these symptoms is warranted, and no new scales are needed until the available scales are fully tested clinimetrically.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 24`
A06				`@2 5`
A08	`01`	`1`	`ENG`	`@1 Dysautonomia Rating Scales in Parkinson's Disease : Sialorrhea, Dysphagia, and Constipation-Critique and Recommendations by Movement Disorders Task Force on Rating Scales for Parkinson's Disease`
A11	`01`	`1`		`@1 EVATT (Marian L.)`
A11	`02`	`1`		`@1 CHAUDHURI (K. Ray)`
A11	`03`	`1`		`@1 CHOU (Kelvin L.)`
A11	`04`	`1`		`@1 CUBO (Ester)`
A11	`05`	`1`		`@1 HINSON (Vanessa)`
A11	`06`	`1`		`@1 KOMPOLITI (Katie)`
A11	`07`	`1`		`@1 CHENGWU YANG`
A11	`08`	`1`		`@1 POEWE (Werner)`
A11	`09`	`1`		`@1 RASCOL (Olivier)`
A11	`10`	`1`		`@1 SAMPAIO (Cristina)`
A11	`11`	`1`		`@1 STEBBINS (Glenn T.)`
A11	`12`	`1`		`@1 GOETZ (Christopher G.)`
A14	`01`			`@1 Section of Movement Disorders, Department of Neurology, Emory University School of Medicine @2 Atlanta, Georgia @3 USA @Z 1 aut.`
A14	`02`			`@1 National Parkinson Foundation Centre of Excellence, Kings College Hospital, Institute of Psychiatry @2 London @3 GBR @Z 2 aut.`
A14	`03`			`@1 Department of Neurology, University of Michigan Medical School @2 Ann Arhor, Michigan @3 USA @Z 3 aut.`
A14	`04`			`@1 Neurology Department, Hospital General Yague @2 Burgos @3 ESP @Z 4 aut.`
A14	`05`			`@1 Department of Neurosciences, Medical University of South Carolina @2 Charleston, South Carolina @3 USA @Z 5 aut. @Z 7 aut.`
A14	`06`			`@1 Department of Neurological Services, Rush University School of Medicine @2 Chicago, Illinois @3 USA @Z 6 aut. @Z 11 aut. @Z 12 aut.`
A14	`07`			`@1 Department of Biostatistics, Medical University of South Carolina @2 Charleston, South Carolina @3 USA @Z 8 aut.`
A14	`08`			`@1 Department of Neurology, University Hospital @2 Innsbruck @3 AUT @Z 9 aut.`
A14	`09`			`@1 Laboratoire de Pharmacologie Médicale et Clinique @2 Toulouse @3 FRA @Z 10 aut.`
A14	`10`			`@1 Laboratory of Clinical Pharmacology and Therapeutics, Lisbon School of Medicine @2 Lisbon @3 PRT`
A20				`@1 635-646`
A21				`@1 2009`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000186090170010`
A44				`@0 0000 @1 © 2009 INIST-CNRS. All rights reserved.`
A45				`@0 70 ref.`
A47	`01`	`1`		`@0 09-0218136`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Upper and lower gastrointestinal dysautonomia symptoms (GIDS)-sialorrhea, dysphagia, and constipation are common in Parkinson's disease (PD) and often socially as well as physically disabling for patients. Available invasive quantitative measures for assessing these symptoms and their response to therapy are time-consuming, require specialized equipment, can cause patient discomfort and present patients with risk. The Movement Disorders Society commissioned a task force to assess available clinical rating scales, critique their clinimetric properties, and make recommendations regarding their clinical utility. Six clinical researchers and a biostatistician systematically searched the literature for scales of sialorrhea, dysphagia, and constipation, evaluated the scales' previous use, performance parameters, and quality of validation data (if available). A scale was designated "Recommended" if the scale was used in clinical studies beyond the group that developed it, has been specifically used in PD reports, and clinimetric studies have established that it is a valid, reliable, and sensitive. "Suggested" scales met at least part of the above criteria, but fell short of meeting all. Based on the systematic review, scales for individual symptoms of sialorrhea, dysphagia, and constipation were identified along with three global scales that include these symptoms in the context of assessing dysautonomia or nonmotor symptoms. Three sialorrhea scales met criteria for Suggested: Drooling Severity and Frequency Scale (DSFS), Drooling Rating Scale, and Sialorrhea Clinical Scale for PD (SCS-PD). Two dysphagia scales, the Swallowing Disturbance Questionnaire (SDQ) and Dysphagia-Specific Quality of Life (SWAL-QOL), met criteria for Suggested. Although Rome III constipation module is widely accepted in the gastroenterology community, and the earlier version from the Rome II criteria has been used in a single study of PD patients, neither met criteria for Suggested or Recommended. Among the global scales, the Scales for Outcomes in PD-Autonomic (SCOPA-AUT) and Nonmotor Symptoms Questionnaire for PD (NMSQuest) both met criteria for Recommended, and the Nonmotor Symptoms Scale (NMSS) met criteria for Suggested; however, none specifically focuses on the target gastrointestinal symptoms (sialorrhea, dysphagia, and constipation) of this report. A very small number of rating scales have been applied to studies of gastrointestinal-related dysautonomia in PD. Only two scales met "Recommended" criteria and neither focuses specifically on the symptoms of sialorrhea, dysphagia, and constipation. Further scale testing in PD among the scales that focus on these symptoms is warranted, and no new scales are needed until the available scales are fully tested clinimetrically.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Maladie de Parkinson @2 NM @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @2 NM @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @2 NM @5 01`
C03	`02`	`X`	`FRE`	`@0 Dysphagie @5 02`
C03	`02`	`X`	`ENG`	`@0 Dysphagia @5 02`
C03	`02`	`X`	`SPA`	`@0 Disfagia @5 02`
C03	`03`	`X`	`FRE`	`@0 Constipation @5 03`
C03	`03`	`X`	`ENG`	`@0 Constipation @5 03`
C03	`03`	`X`	`SPA`	`@0 Constipación @5 03`
C03	`04`	`X`	`FRE`	`@0 Pathologie du système nerveux @5 04`
C03	`04`	`X`	`ENG`	`@0 Nervous system diseases @5 04`
C03	`04`	`X`	`SPA`	`@0 Sistema nervioso patología @5 04`
C03	`05`	`X`	`FRE`	`@0 Sialorrhée @5 09`
C03	`05`	`X`	`ENG`	`@0 Sialorrhea @5 09`
C03	`05`	`X`	`SPA`	`@0 Sialorrea @5 09`
C03	`06`	`X`	`FRE`	`@0 Recommandation @5 10`
C03	`06`	`X`	`ENG`	`@0 Recommendation @5 10`
C03	`06`	`X`	`SPA`	`@0 Recomendación @5 10`
C03	`07`	`X`	`FRE`	`@0 Force @5 11`
C03	`07`	`X`	`ENG`	`@0 Force @5 11`
C03	`07`	`X`	`SPA`	`@0 Fuerza @5 11`
C03	`08`	`X`	`FRE`	`@0 Gastrointestinal @5 12`
C03	`08`	`X`	`ENG`	`@0 Gastrointestinal @5 12`
C03	`08`	`X`	`SPA`	`@0 Gastrointestinal @5 12`
C07	`01`	`X`	`FRE`	`@0 Pathologie de l'encéphale @5 37`
C07	`01`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`01`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Syndrome extrapyramidal @5 38`
C07	`02`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 38`
C07	`03`	`X`	`FRE`	`@0 Maladie dégénérative @5 39`
C07	`03`	`X`	`ENG`	`@0 Degenerative disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 39`
C07	`04`	`X`	`FRE`	`@0 Pathologie du système nerveux central @5 40`
C07	`04`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
C07	`05`	`X`	`FRE`	`@0 Stomatologie @5 42`
C07	`05`	`X`	`ENG`	`@0 Stomatology @5 42`
C07	`05`	`X`	`SPA`	`@0 Estomatología @5 42`
C07	`06`	`X`	`FRE`	`@0 Pathologie de l'appareil digestif @5 43`
C07	`06`	`X`	`ENG`	`@0 Digestive diseases @5 43`
C07	`06`	`X`	`SPA`	`@0 Aparato digestivo patología @5 43`
C07	`07`	`X`	`FRE`	`@0 Pathologie de l'oesophage @5 44`
C07	`07`	`X`	`ENG`	`@0 Esophageal disease @5 44`
C07	`07`	`X`	`SPA`	`@0 Esófago patología @5 44`
C07	`08`	`X`	`FRE`	`@0 Pathologie de l'intestin @5 45`
C07	`08`	`X`	`ENG`	`@0 Intestinal disease @5 45`
C07	`08`	`X`	`SPA`	`@0 Intestino patología @5 45`
N21				`@1 159`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 09-0218136 INIST
ET :	Dysautonomia Rating Scales in Parkinson's Disease : Sialorrhea, Dysphagia, and Constipation-Critique and Recommendations by Movement Disorders Task Force on Rating Scales for Parkinson's Disease
AU :	EVATT (Marian L.); CHAUDHURI (K. Ray); CHOU (Kelvin L.); CUBO (Ester); HINSON (Vanessa); KOMPOLITI (Katie); CHENGWU YANG; POEWE (Werner); RASCOL (Olivier); SAMPAIO (Cristina); STEBBINS (Glenn T.); GOETZ (Christopher G.)
AF :	Section of Movement Disorders, Department of Neurology, Emory University School of Medicine/Atlanta, Georgia/Etats-Unis (1 aut.); National Parkinson Foundation Centre of Excellence, Kings College Hospital, Institute of Psychiatry/London/Royaume-Uni (2 aut.); Department of Neurology, University of Michigan Medical School/Ann Arhor, Michigan/Etats-Unis (3 aut.); Neurology Department, Hospital General Yague/Burgos/Espagne (4 aut.); Department of Neurosciences, Medical University of South Carolina/Charleston, South Carolina/Etats-Unis (5 aut., 7 aut.); Department of Neurological Services, Rush University School of Medicine/Chicago, Illinois/Etats-Unis (6 aut., 11 aut., 12 aut.); Department of Biostatistics, Medical University of South Carolina/Charleston, South Carolina/Etats-Unis (8 aut.); Department of Neurology, University Hospital/Innsbruck/Autriche (9 aut.); Laboratoire de Pharmacologie Médicale et Clinique/Toulouse/France (10 aut.); Laboratory of Clinical Pharmacology and Therapeutics, Lisbon School of Medicine/Lisbon/Portugal
DT :	Publication en série; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2009; Vol. 24; No. 5; Pp. 635-646; Bibl. 70 ref.
LA :	Anglais
EA :	Upper and lower gastrointestinal dysautonomia symptoms (GIDS)-sialorrhea, dysphagia, and constipation are common in Parkinson's disease (PD) and often socially as well as physically disabling for patients. Available invasive quantitative measures for assessing these symptoms and their response to therapy are time-consuming, require specialized equipment, can cause patient discomfort and present patients with risk. The Movement Disorders Society commissioned a task force to assess available clinical rating scales, critique their clinimetric properties, and make recommendations regarding their clinical utility. Six clinical researchers and a biostatistician systematically searched the literature for scales of sialorrhea, dysphagia, and constipation, evaluated the scales' previous use, performance parameters, and quality of validation data (if available). A scale was designated "Recommended" if the scale was used in clinical studies beyond the group that developed it, has been specifically used in PD reports, and clinimetric studies have established that it is a valid, reliable, and sensitive. "Suggested" scales met at least part of the above criteria, but fell short of meeting all. Based on the systematic review, scales for individual symptoms of sialorrhea, dysphagia, and constipation were identified along with three global scales that include these symptoms in the context of assessing dysautonomia or nonmotor symptoms. Three sialorrhea scales met criteria for Suggested: Drooling Severity and Frequency Scale (DSFS), Drooling Rating Scale, and Sialorrhea Clinical Scale for PD (SCS-PD). Two dysphagia scales, the Swallowing Disturbance Questionnaire (SDQ) and Dysphagia-Specific Quality of Life (SWAL-QOL), met criteria for Suggested. Although Rome III constipation module is widely accepted in the gastroenterology community, and the earlier version from the Rome II criteria has been used in a single study of PD patients, neither met criteria for Suggested or Recommended. Among the global scales, the Scales for Outcomes in PD-Autonomic (SCOPA-AUT) and Nonmotor Symptoms Questionnaire for PD (NMSQuest) both met criteria for Recommended, and the Nonmotor Symptoms Scale (NMSS) met criteria for Suggested; however, none specifically focuses on the target gastrointestinal symptoms (sialorrhea, dysphagia, and constipation) of this report. A very small number of rating scales have been applied to studies of gastrointestinal-related dysautonomia in PD. Only two scales met "Recommended" criteria and neither focuses specifically on the symptoms of sialorrhea, dysphagia, and constipation. Further scale testing in PD among the scales that focus on these symptoms is warranted, and no new scales are needed until the available scales are fully tested clinimetrically.
CC :	002B17; 002B17G
FD :	Maladie de Parkinson; Dysphagie; Constipation; Pathologie du système nerveux; Sialorrhée; Recommandation; Force; Gastrointestinal
FG :	Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central; Stomatologie; Pathologie de l'appareil digestif; Pathologie de l'oesophage; Pathologie de l'intestin
ED :	Parkinson disease; Dysphagia; Constipation; Nervous system diseases; Sialorrhea; Recommendation; Force; Gastrointestinal
EG :	Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Stomatology; Digestive diseases; Esophageal disease; Intestinal disease
SD :	Parkinson enfermedad; Disfagia; Constipación; Sistema nervioso patología; Sialorrea; Recomendación; Fuerza; Gastrointestinal
LO :	INIST-20953.354000186090170010
ID :	09-0218136

Links to Exploration step

Pascal:09-0218136

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Dysautonomia Rating Scales in Parkinson's Disease : Sialorrhea, Dysphagia, and Constipation-Critique and Recommendations by Movement Disorders Task Force on Rating Scales for Parkinson's Disease</title>
<author><name sortKey="Evatt, Marian L" sort="Evatt, Marian L" uniqKey="Evatt M" first="Marian L." last="Evatt">Marian L. Evatt</name>
<affiliation><inist:fA14 i1="01"><s1>Section of Movement Disorders, Department of Neurology, Emory University School of Medicine</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="10"><s1>Laboratory of Clinical Pharmacology and Therapeutics, Lisbon School of Medicine</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Chaudhuri, K Ray" sort="Chaudhuri, K Ray" uniqKey="Chaudhuri K" first="K. Ray" last="Chaudhuri">K. Ray Chaudhuri</name>
<affiliation><inist:fA14 i1="02"><s1>National Parkinson Foundation Centre of Excellence, Kings College Hospital, Institute of Psychiatry</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Chou, Kelvin L" sort="Chou, Kelvin L" uniqKey="Chou K" first="Kelvin L." last="Chou">Kelvin L. Chou</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, University of Michigan Medical School</s1>
<s2>Ann Arhor, Michigan</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Cubo, Ester" sort="Cubo, Ester" uniqKey="Cubo E" first="Ester" last="Cubo">Ester Cubo</name>
<affiliation><inist:fA14 i1="04"><s1>Neurology Department, Hospital General Yague</s1>
<s2>Burgos</s2>
<s3>ESP</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hinson, Vanessa" sort="Hinson, Vanessa" uniqKey="Hinson V" first="Vanessa" last="Hinson">Vanessa Hinson</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Neurosciences, Medical University of South Carolina</s1>
<s2>Charleston, South Carolina</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kompoliti, Katie" sort="Kompoliti, Katie" uniqKey="Kompoliti K" first="Katie" last="Kompoliti">Katie Kompoliti</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Neurological Services, Rush University School of Medicine</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Chengwu Yang" sort="Chengwu Yang" uniqKey="Chengwu Yang" last="Chengwu Yang">CHENGWU YANG</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Neurosciences, Medical University of South Carolina</s1>
<s2>Charleston, South Carolina</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Biostatistics, Medical University of South Carolina</s1>
<s2>Charleston, South Carolina</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation><inist:fA14 i1="08"><s1>Department of Neurology, University Hospital</s1>
<s2>Innsbruck</s2>
<s3>AUT</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name>
<affiliation><inist:fA14 i1="09"><s1>Laboratoire de Pharmacologie Médicale et Clinique</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stebbins, Glenn T" sort="Stebbins, Glenn T" uniqKey="Stebbins G" first="Glenn T." last="Stebbins">Glenn T. Stebbins</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Neurological Services, Rush University School of Medicine</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Neurological Services, Rush University School of Medicine</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">09-0218136</idno>
<date when="2009">2009</date>
<idno type="stanalyst">PASCAL 09-0218136 INIST</idno>
<idno type="RBID">Pascal:09-0218136</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000F25</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Dysautonomia Rating Scales in Parkinson's Disease : Sialorrhea, Dysphagia, and Constipation-Critique and Recommendations by Movement Disorders Task Force on Rating Scales for Parkinson's Disease</title>
<author><name sortKey="Evatt, Marian L" sort="Evatt, Marian L" uniqKey="Evatt M" first="Marian L." last="Evatt">Marian L. Evatt</name>
<affiliation><inist:fA14 i1="01"><s1>Section of Movement Disorders, Department of Neurology, Emory University School of Medicine</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="10"><s1>Laboratory of Clinical Pharmacology and Therapeutics, Lisbon School of Medicine</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Chaudhuri, K Ray" sort="Chaudhuri, K Ray" uniqKey="Chaudhuri K" first="K. Ray" last="Chaudhuri">K. Ray Chaudhuri</name>
<affiliation><inist:fA14 i1="02"><s1>National Parkinson Foundation Centre of Excellence, Kings College Hospital, Institute of Psychiatry</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Chou, Kelvin L" sort="Chou, Kelvin L" uniqKey="Chou K" first="Kelvin L." last="Chou">Kelvin L. Chou</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, University of Michigan Medical School</s1>
<s2>Ann Arhor, Michigan</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Cubo, Ester" sort="Cubo, Ester" uniqKey="Cubo E" first="Ester" last="Cubo">Ester Cubo</name>
<affiliation><inist:fA14 i1="04"><s1>Neurology Department, Hospital General Yague</s1>
<s2>Burgos</s2>
<s3>ESP</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hinson, Vanessa" sort="Hinson, Vanessa" uniqKey="Hinson V" first="Vanessa" last="Hinson">Vanessa Hinson</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Neurosciences, Medical University of South Carolina</s1>
<s2>Charleston, South Carolina</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kompoliti, Katie" sort="Kompoliti, Katie" uniqKey="Kompoliti K" first="Katie" last="Kompoliti">Katie Kompoliti</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Neurological Services, Rush University School of Medicine</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Chengwu Yang" sort="Chengwu Yang" uniqKey="Chengwu Yang" last="Chengwu Yang">CHENGWU YANG</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Neurosciences, Medical University of South Carolina</s1>
<s2>Charleston, South Carolina</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Biostatistics, Medical University of South Carolina</s1>
<s2>Charleston, South Carolina</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation><inist:fA14 i1="08"><s1>Department of Neurology, University Hospital</s1>
<s2>Innsbruck</s2>
<s3>AUT</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name>
<affiliation><inist:fA14 i1="09"><s1>Laboratoire de Pharmacologie Médicale et Clinique</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stebbins, Glenn T" sort="Stebbins, Glenn T" uniqKey="Stebbins G" first="Glenn T." last="Stebbins">Glenn T. Stebbins</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Neurological Services, Rush University School of Medicine</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Neurological Services, Rush University School of Medicine</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Constipation</term>
<term>Dysphagia</term>
<term>Force</term>
<term>Gastrointestinal</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Recommendation</term>
<term>Sialorrhea</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term>
<term>Dysphagie</term>
<term>Constipation</term>
<term>Pathologie du   système nerveux</term>
<term>Sialorrhée</term>
<term>Recommandation</term>
<term>Force</term>
<term>Gastrointestinal</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Upper and lower gastrointestinal dysautonomia symptoms (GIDS)-sialorrhea, dysphagia, and constipation are common in Parkinson's disease (PD) and often socially as well as physically disabling for patients. Available invasive quantitative measures for assessing these symptoms and their response to therapy are time-consuming, require specialized equipment, can cause patient discomfort and present patients with risk. The Movement Disorders Society commissioned a task force to assess available clinical rating scales, critique their clinimetric properties, and make recommendations regarding their clinical utility. Six clinical researchers and a biostatistician systematically searched the literature for scales of sialorrhea, dysphagia, and constipation, evaluated the scales' previous use, performance parameters, and quality of validation data (if available). A scale was designated "Recommended" if the scale was used in clinical studies beyond the group that developed it, has been specifically used in PD reports, and clinimetric studies have established that it is a valid, reliable, and sensitive. "Suggested" scales met at least part of the above criteria, but fell short of meeting all. Based on the systematic review, scales for individual symptoms of sialorrhea, dysphagia, and constipation were identified along with three global scales that include these symptoms in the context of assessing dysautonomia or nonmotor symptoms. Three sialorrhea scales met criteria for Suggested: Drooling Severity and Frequency Scale (DSFS), Drooling Rating Scale, and Sialorrhea Clinical Scale for PD (SCS-PD). Two dysphagia scales, the Swallowing Disturbance Questionnaire (SDQ) and Dysphagia-Specific Quality of Life (SWAL-QOL), met criteria for Suggested. Although Rome III constipation module is widely accepted in the gastroenterology community, and the earlier version from the Rome II criteria has been used in a single study of PD patients, neither met criteria for Suggested or Recommended. Among the global scales, the Scales for Outcomes in PD-Autonomic (SCOPA-AUT) and Nonmotor Symptoms Questionnaire for PD (NMSQuest) both met criteria for Recommended, and the Nonmotor Symptoms Scale (NMSS) met criteria for Suggested; however, none specifically focuses on the target gastrointestinal symptoms (sialorrhea, dysphagia, and constipation) of this report. A very small number of rating scales have been applied to studies of gastrointestinal-related dysautonomia in PD. Only two scales met "Recommended" criteria and neither focuses specifically on the symptoms of sialorrhea, dysphagia, and constipation. Further scale testing in PD among the scales that focus on these symptoms is warranted, and no new scales are needed until the available scales are fully tested clinimetrically.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>24</s2>
</fA05>
<fA06><s2>5</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Dysautonomia Rating Scales in Parkinson's Disease : Sialorrhea, Dysphagia, and Constipation-Critique and Recommendations by Movement Disorders Task Force on Rating Scales for Parkinson's Disease</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>EVATT (Marian L.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>CHAUDHURI (K. Ray)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>CHOU (Kelvin L.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>CUBO (Ester)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>HINSON (Vanessa)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>KOMPOLITI (Katie)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>CHENGWU YANG</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>POEWE (Werner)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>RASCOL (Olivier)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>SAMPAIO (Cristina)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>STEBBINS (Glenn T.)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>GOETZ (Christopher G.)</s1>
</fA11>
<fA14 i1="01"><s1>Section of Movement Disorders, Department of Neurology, Emory University School of Medicine</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>National Parkinson Foundation Centre of Excellence, Kings College Hospital, Institute of Psychiatry</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Neurology, University of Michigan Medical School</s1>
<s2>Ann Arhor, Michigan</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Neurology Department, Hospital General Yague</s1>
<s2>Burgos</s2>
<s3>ESP</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Neurosciences, Medical University of South Carolina</s1>
<s2>Charleston, South Carolina</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Department of Neurological Services, Rush University School of Medicine</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Department of Biostatistics, Medical University of South Carolina</s1>
<s2>Charleston, South Carolina</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Department of Neurology, University Hospital</s1>
<s2>Innsbruck</s2>
<s3>AUT</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Laboratoire de Pharmacologie Médicale et Clinique</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>Laboratory of Clinical Pharmacology and Therapeutics, Lisbon School of Medicine</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
</fA14>
<fA20><s1>635-646</s1>
</fA20>
<fA21><s1>2009</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000186090170010</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2009 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>70 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>09-0218136</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Upper and lower gastrointestinal dysautonomia symptoms (GIDS)-sialorrhea, dysphagia, and constipation are common in Parkinson's disease (PD) and often socially as well as physically disabling for patients. Available invasive quantitative measures for assessing these symptoms and their response to therapy are time-consuming, require specialized equipment, can cause patient discomfort and present patients with risk. The Movement Disorders Society commissioned a task force to assess available clinical rating scales, critique their clinimetric properties, and make recommendations regarding their clinical utility. Six clinical researchers and a biostatistician systematically searched the literature for scales of sialorrhea, dysphagia, and constipation, evaluated the scales' previous use, performance parameters, and quality of validation data (if available). A scale was designated "Recommended" if the scale was used in clinical studies beyond the group that developed it, has been specifically used in PD reports, and clinimetric studies have established that it is a valid, reliable, and sensitive. "Suggested" scales met at least part of the above criteria, but fell short of meeting all. Based on the systematic review, scales for individual symptoms of sialorrhea, dysphagia, and constipation were identified along with three global scales that include these symptoms in the context of assessing dysautonomia or nonmotor symptoms. Three sialorrhea scales met criteria for Suggested: Drooling Severity and Frequency Scale (DSFS), Drooling Rating Scale, and Sialorrhea Clinical Scale for PD (SCS-PD). Two dysphagia scales, the Swallowing Disturbance Questionnaire (SDQ) and Dysphagia-Specific Quality of Life (SWAL-QOL), met criteria for Suggested. Although Rome III constipation module is widely accepted in the gastroenterology community, and the earlier version from the Rome II criteria has been used in a single study of PD patients, neither met criteria for Suggested or Recommended. Among the global scales, the Scales for Outcomes in PD-Autonomic (SCOPA-AUT) and Nonmotor Symptoms Questionnaire for PD (NMSQuest) both met criteria for Recommended, and the Nonmotor Symptoms Scale (NMSS) met criteria for Suggested; however, none specifically focuses on the target gastrointestinal symptoms (sialorrhea, dysphagia, and constipation) of this report. A very small number of rating scales have been applied to studies of gastrointestinal-related dysautonomia in PD. Only two scales met "Recommended" criteria and neither focuses specifically on the symptoms of sialorrhea, dysphagia, and constipation. Further scale testing in PD among the scales that focus on these symptoms is warranted, and no new scales are needed until the available scales are fully tested clinimetrically.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Dysphagie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Dysphagia</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Disfagia</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Constipation</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Constipation</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Constipación</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Pathologie du   système nerveux</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Sialorrhée</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Sialorrhea</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Sialorrea</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Recommandation</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Recommendation</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Recomendación</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Force</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Force</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Fuerza</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Gastrointestinal</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Gastrointestinal</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Gastrointestinal</s0>
<s5>12</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Pathologie du   système nerveux central</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Stomatologie</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Stomatology</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Estomatología</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Pathologie de l'appareil digestif</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Digestive diseases</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Aparato digestivo patología</s0>
<s5>43</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Pathologie de l'oesophage</s0>
<s5>44</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Esophageal disease</s0>
<s5>44</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Esófago patología</s0>
<s5>44</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Pathologie de l'intestin</s0>
<s5>45</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Intestinal disease</s0>
<s5>45</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Intestino patología</s0>
<s5>45</s5>
</fC07>
<fN21><s1>159</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 09-0218136 INIST</NO>
<ET>Dysautonomia Rating Scales in Parkinson's Disease : Sialorrhea, Dysphagia, and Constipation-Critique and Recommendations by Movement Disorders Task Force on Rating Scales for Parkinson's Disease</ET>
<AU>EVATT (Marian L.); CHAUDHURI (K. Ray); CHOU (Kelvin L.); CUBO (Ester); HINSON (Vanessa); KOMPOLITI (Katie); CHENGWU YANG; POEWE (Werner); RASCOL (Olivier); SAMPAIO (Cristina); STEBBINS (Glenn T.); GOETZ (Christopher G.)</AU>
<AF>Section of Movement Disorders, Department of Neurology, Emory University School of Medicine/Atlanta, Georgia/Etats-Unis (1 aut.); National Parkinson Foundation Centre of Excellence, Kings College Hospital, Institute of Psychiatry/London/Royaume-Uni (2 aut.); Department of Neurology, University of Michigan Medical School/Ann Arhor, Michigan/Etats-Unis (3 aut.); Neurology Department, Hospital General Yague/Burgos/Espagne (4 aut.); Department of Neurosciences, Medical University of South Carolina/Charleston, South Carolina/Etats-Unis (5 aut., 7 aut.); Department of Neurological Services, Rush University School of Medicine/Chicago, Illinois/Etats-Unis (6 aut., 11 aut., 12 aut.); Department of Biostatistics, Medical University of South Carolina/Charleston, South Carolina/Etats-Unis (8 aut.); Department of Neurology, University Hospital/Innsbruck/Autriche (9 aut.); Laboratoire de Pharmacologie Médicale et Clinique/Toulouse/France (10 aut.); Laboratory of Clinical Pharmacology and Therapeutics, Lisbon School of Medicine/Lisbon/Portugal</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2009; Vol. 24; No. 5; Pp. 635-646; Bibl. 70 ref.</SO>
<LA>Anglais</LA>
<EA>Upper and lower gastrointestinal dysautonomia symptoms (GIDS)-sialorrhea, dysphagia, and constipation are common in Parkinson's disease (PD) and often socially as well as physically disabling for patients. Available invasive quantitative measures for assessing these symptoms and their response to therapy are time-consuming, require specialized equipment, can cause patient discomfort and present patients with risk. The Movement Disorders Society commissioned a task force to assess available clinical rating scales, critique their clinimetric properties, and make recommendations regarding their clinical utility. Six clinical researchers and a biostatistician systematically searched the literature for scales of sialorrhea, dysphagia, and constipation, evaluated the scales' previous use, performance parameters, and quality of validation data (if available). A scale was designated "Recommended" if the scale was used in clinical studies beyond the group that developed it, has been specifically used in PD reports, and clinimetric studies have established that it is a valid, reliable, and sensitive. "Suggested" scales met at least part of the above criteria, but fell short of meeting all. Based on the systematic review, scales for individual symptoms of sialorrhea, dysphagia, and constipation were identified along with three global scales that include these symptoms in the context of assessing dysautonomia or nonmotor symptoms. Three sialorrhea scales met criteria for Suggested: Drooling Severity and Frequency Scale (DSFS), Drooling Rating Scale, and Sialorrhea Clinical Scale for PD (SCS-PD). Two dysphagia scales, the Swallowing Disturbance Questionnaire (SDQ) and Dysphagia-Specific Quality of Life (SWAL-QOL), met criteria for Suggested. Although Rome III constipation module is widely accepted in the gastroenterology community, and the earlier version from the Rome II criteria has been used in a single study of PD patients, neither met criteria for Suggested or Recommended. Among the global scales, the Scales for Outcomes in PD-Autonomic (SCOPA-AUT) and Nonmotor Symptoms Questionnaire for PD (NMSQuest) both met criteria for Recommended, and the Nonmotor Symptoms Scale (NMSS) met criteria for Suggested; however, none specifically focuses on the target gastrointestinal symptoms (sialorrhea, dysphagia, and constipation) of this report. A very small number of rating scales have been applied to studies of gastrointestinal-related dysautonomia in PD. Only two scales met "Recommended" criteria and neither focuses specifically on the symptoms of sialorrhea, dysphagia, and constipation. Further scale testing in PD among the scales that focus on these symptoms is warranted, and no new scales are needed until the available scales are fully tested clinimetrically.</EA>
<CC>002B17; 002B17G</CC>
<FD>Maladie de Parkinson; Dysphagie; Constipation; Pathologie du système nerveux; Sialorrhée; Recommandation; Force; Gastrointestinal</FD>
<FG>Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du   système nerveux central; Stomatologie; Pathologie de l'appareil digestif; Pathologie de l'oesophage; Pathologie de l'intestin</FG>
<ED>Parkinson disease; Dysphagia; Constipation; Nervous system diseases; Sialorrhea; Recommendation; Force; Gastrointestinal</ED>
<EG>Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Stomatology; Digestive diseases; Esophageal disease; Intestinal disease</EG>
<SD>Parkinson enfermedad; Disfagia; Constipación; Sistema nervioso patología; Sialorrea; Recomendación; Fuerza; Gastrointestinal</SD>
<LO>INIST-20953.354000186090170010</LO>
<ID>09-0218136</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F25 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000F25 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:09-0218136
   |texte=   Dysautonomia Rating Scales in Parkinson's Disease : Sialorrhea, Dysphagia, and Constipation-Critique and Recommendations by Movement Disorders Task Force on Rating Scales for Parkinson's Disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Dysautonomia Rating Scales in Parkinson's Disease : Sialorrhea, Dysphagia, and Constipation-Critique and Recommendations by Movement Disorders Task Force on Rating Scales for Parkinson's Disease

Dysautonomia Rating Scales in Parkinson's Disease : Sialorrhea, Dysphagia, and Constipation-Critique and Recommendations by Movement Disorders Task Force on Rating Scales for Parkinson's Disease

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri